Children's Medical Research Institute, The University of Sydney, 214 Hawkesbury Road, Westmead, NSW, 2145, Australia.
Mol Cancer. 2013 Jan 17;12:4. doi: 10.1186/1476-4598-12-4.
During metaphase clathrin stabilises the mitotic spindle kinetochore (K)-fibres. Many anti-mitotic compounds target microtubule dynamics. Pitstop 2™ is the first small molecule inhibitor of clathrin terminal domain and inhibits clathrin-mediated endocytosis. We investigated its effects on a second function for clathrin in mitosis.
Pitstop 2 did not impair clathrin recruitment to the spindle but disrupted its function once stationed there. Pitstop 2 trapped HeLa cells in metaphase through loss of mitotic spindle integrity and activation of the spindle assembly checkpoint, phenocopying clathrin depletion and aurora A kinase inhibition.
Pitstop 2 is therefore a new tool for investigating clathrin spindle dynamics. Pitstop 2 reduced viability in dividing HeLa cells, without affecting dividing non-cancerous NIH3T3 cells, suggesting that clathrin is a possible novel anti-mitotic drug target.
在有丝分裂中期,网格蛋白稳定着有丝分裂纺锤体的动粒(K)-纤维。许多抗有丝分裂的化合物靶向微管动力学。Pitstop 2™ 是第一个网格蛋白末端结构域的小分子抑制剂,能抑制网格蛋白介导的内吞作用。我们研究了它对网格蛋白在有丝分裂中的第二个功能的影响。
Pitstop 2 并没有损害网格蛋白向纺锤体的募集,但一旦固定在那里,就会破坏其功能。Pitstop 2 通过有丝分裂纺锤体完整性的丧失和纺锤体组装检查点的激活,将 HeLa 细胞困在中期,这与网格蛋白耗竭和 Aurora A 激酶抑制的表型相似。
因此,Pitstop 2 是研究网格蛋白纺锤体动力学的新工具。Pitstop 2 降低了分裂的 HeLa 细胞的活力,而不影响分裂的非癌细胞系 NIH3T3 细胞,这表明网格蛋白可能是一种新的抗有丝分裂药物靶点。